Purpose

Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present multicenter study (conducted through the Exposure Therapy Consortium) is designed to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 70 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Self-report of 18 - 70 years of age - Current student at a participating University - Ability to read English to provide informed consent - Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet). - For Phase 2: speech anxiety scale score of ≥ 18 on the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS)

Exclusion Criteria

  • Previous participation (i.e., no participant may take the survey more than once).

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Intervention Model Description
Single session VR-based exposure therapy
Primary Purpose
Treatment
Masking
None (Open Label)
Masking Description
Participants are blind to the study hypothesis and outcomes are assessed by participant self-report.

Arm Groups

ArmDescriptionAssigned Intervention
Other
Positive or Negative Mood Induction via film clips
VR exposure is the only intervention, but the VR intervention is conducted following either positive or negative mood induction.
  • Behavioral: Single-session VR exposure intervention
    VR exposure is the only intervention, but the VR intervention is conducted following either positive or negative mood induction.

Recruiting Locations

Boston University
Boston, Massachusetts 02215
Contact:
Laura J. Long, Ph.D.
617-353-9610
ljlong@bu.edu

More Details

Status
Recruiting
Sponsor
Boston University Charles River Campus

Study Contact

Michael Otto, PhD
6173539610
mwotto@bu.edu

Detailed Description

The goal of this multicenter clinical trial is to examine predictors of VR exposure therapy outcomes for college students with public speaking anxiety following a positive or negative mood induction. The overarching aim of the present study is to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism. State affect is manipulated at an experimental level with affect induction procedures; trait positive affectivity is measured at baseline. The study involves three phases: (1) initial screening, (2) in-person assessment and brief exposure intervention for a subset of participants with elevated public speaking anxiety, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on a public speaking anxiety scale will be assigned to a positive or negative mood induction condition prior to undergoing VR-based exposure therapy. Public speaking and social anxiety outcomes are measured immediately post-intervention and one week later. The one-week follow-up assessment represents the primary outcome.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.